Article

Not One, But Five: Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication and Post-Translational Infection Mechanisms

2020-04-27

Abstract excerpt

The novel coronavirus SARS-CoV2, the causative agent of the worldwide pandemic disease COVID-19, emerged in December 2019 forcing lockdown of communities in many countries. The absence of specific drugs and vaccines, the rapid transmission of the virus, and the increasing number of deaths worldwide have necessitated the need to discover substances that can be tapped for drug development. With the aid of bioinforma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1e8f6e80-816a-5741-a764-15d9a0294a20
DOI: 10.26434/chemrxiv.12170424.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Not One, But Five: Virtual Screening-Driven Drug Discovery of SARS-CoV2 Enzyme Inhibitors Targeting Viral Attachment, Replication and Post-Translational Infection MechanismsDOI 10.26434/chemrxiv.12170424.v2Read

Genetic Algorithm-Based Docking of Potent Inhibitors Against SARS-CoV-2 Main Protease: A Comparison Between Natural Products and Synthetic Drugs.Semantic proximity Read

Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approachSemantic proximity Read

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read

Evaluation of the inhibitory potential of Bioactive compounds against SARS-CoV2 by in-silico approachSemantic proximity Read

Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative modelSemantic proximity Read

Computational Approach for Covalent Lead Identification against Spike Glycoprotein of SARS-CoV-2Semantic proximity Read

Bioinformatic study to discover natural molecules with activity against COVID-19Semantic proximity Read

Nature Potential for COVID-19: Targeting SARS-CoV-2 Mpro Inhibitor with Bioactive CompoundSemantic proximity Read

Based on Principles and Insights of COVID-19 Epidemiology, Genome Sequencing, and Pathogenesis: Retrospective Analysis of Sinigrin and ProlixinRX (Fluphenazine) Provides Off-Label Drug Candidates.Semantic proximity Read

Multi-reference poly-conformational computational methods for de-novo design, optimization, and repositioning of pharmaceutical compoundsSemantic proximity Read

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugsSemantic proximity Read

Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Non-structural Proteins InhibitorsSemantic proximity Read